Company news

Charles River Laboratories International, Inc. news in 2025

Charles River Laboratories International, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort

December 11, 2025

Akadeum Life Sciences Announces Establishment of the Akadeum CDMO Alliance Program

December 9, 2025

Charles River Laboratories to Present at Evercore Healthcare Conference

December 1, 2025

Charles River Laboratories to Present at Jefferies Global Healthcare Conference

November 17, 2025

Charles River Laboratories Provides Update on Strategic Review

November 5, 2025

Charles River Laboratories Announces Third-Quarter 2025 Results

November 5, 2025

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

October 22, 2025

Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities

October 20, 2025

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

October 15, 2025

Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call

October 14, 2025

Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

October 8, 2025

Jacobi Partners with Charles River to Empower Scalable Model Portfolio Management

September 23, 2025

Charles River Laboratories Announces Chief Financial Officer Transition

September 16, 2025

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer

September 11, 2025

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

September 8, 2025

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

September 3, 2025

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

August 26, 2025

Charles River Laboratories Announces Second-Quarter 2025 Results

August 6, 2025

Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership

July 31, 2025

Charles River Joins Elly’s Team to Drive Rare Disease Gene Therapy Development

July 22, 2025

Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call

July 15, 2025

Myrtelle Launches Manufacturing of First-in-Class Gene Therapy for Canavan Disease in Strategic Alliance with Charles River and Viralgen

July 8, 2025

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment

June 16, 2025

Charles River Laboratories to Present at William Blair and Jefferies Conferences

June 2, 2025

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research

May 28, 2025

Charles River Laboratories to Present at Bank of America Health Care Conference

May 13, 2025

Charles River Laboratories Announces First-Quarter 2025 Results

May 7, 2025

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

May 7, 2025

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort

April 29, 2025

Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development

April 22, 2025

Calls in 2025

Decks in 2025